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Abstract
Swiprosin-1/EFhd2 (EFhd2) is a cytoskeletal Ca2+ sensor protein strongly expressed in the brain. It has been shown to
interact with mutant tau, which can promote neurodegeneration, but nothing is known about the physiological function of
EFhd2 in the nervous system. To elucidate this question, we analyzed EFhd22/2/lacZ reporter mice and showed that lacZ
was strongly expressed in the cortex, the dentate gyrus, the CA1 and CA2 regions of the hippocampus, the thalamus, and
the olfactory bulb. Immunohistochemistry and western blotting confirmed this pattern and revealed expression of EFhd2
during neuronal maturation. In cortical neurons, EFhd2 was detected in neurites marked by MAP2 and co-localized with pre-
and post-synaptic markers. Approximately one third of EFhd2 associated with a biochemically isolated synaptosome
preparation. There, EFhd2 was mostly confined to the cytosolic and plasma membrane fractions. Both synaptic endocytosis
and exocytosis in primary hippocampal EFhd22/2 neurons were unaltered but transport of synaptophysin-GFP containing
vesicles was enhanced in EFhd22/2 primary hippocampal neurons, and notably, EFhd2 inhibited kinesin mediated
microtubule gliding. Therefore, we found that EFhd2 is a neuronal protein that interferes with kinesin-mediated transport.
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Introduction
Ca2+ ions are crucial second messengers in synaptic transmis-
sion and cytoskeleton function. Ca2+ binding proteins of different
classes play important roles in the brain [1]. Swiprosin-1/EFhd2
(EFhd2) is a proposed Ca2+ sensor protein expressed abundantly in
the brain [2,3], and was shown to interact with tauP301L [4].
EFhd2 consists of a N-terminal region of low complexity with an
alanine stretch, a functional SH3 binding motif [5], two functional
EF hands [2,6] and a C-terminal coiled-coil domain [7]. The
coiled-coil domain of recombinant EFhd2 is responsible for self-
oligomerization in a Ca2+-dependent manner [8] and for the
interaction with mutant tau in brain extracts of JNPL3 mice in
vitro [9]. How EFhd2 may be linked with neurodegenerative
diseases is not known, due to the physiological function of EFhd2
being poorly understood. Though it was previously reported that
EFhd2 is part of conserved functional cytoskeletal and Ca2+
feedback loops in B cells and other systems [2,10], which within
neurons would point towards functions in neurite maintenance
and/or transport.
Anterograde and retrograde axonal transport along microtu-
bules (MTs) of most cargos is mediated by the motor proteins
kinesin and dynein, respectively [11]. Microtubule associated
proteins (MAP) assist these processes by stabilizing MTs. The
MAP tau directly binds and thus stabilizes MT in axons and
microtubule associated protein 2 (MAP2) stabilizes MT in
dendrites [11,12]. Defects in synaptic and transport proteins are
involved in neurodegenerative diseases by interfering with axonal
transport and neural circuit function (reviewed in [13,11]). Axonal
branching during physiological axonal regeneration requires local
destabilization of the MT cytoskeleton [12]. This process requires
detachment of tau from MTs, which can be mediated by the
phosphorylation of tau at many residues [12]. Therefore,
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controlled tau phosphorylation is a critical physiological process
and may be linked with EFhd2 [4].
We therefore tested the hypothesis that EFhd2 controls
cytoskeletal functions in neurons using EFhd2 knock-out/lacZ
knock-in mice. We found that EFhd2 was strongly expressed in the
cortex, hippocampus, thalamus and the olfactory bulb. We
revealed that EFhd2 is has a negative impact on transport of
synaptophysin-GFP containing vesicles in hippocampal neurons.
Specifically, EFhd2 inhibited kinesin mediated microtubule
gliding. Taken together, we propose that EFhd2 is a neuronal
protein that interferes with kinesin activity.
Materials and Methods
Chemicals
All chemicals were purchased from Sigma-Aldrich (Deisenho-
fen; Germany) Merck (Darmstadt; Germany) or Roth (Karlsruhe;
Germany) unless stated otherwise. Cell culture medium and
supplements were obtained from Invitrogen Life Technologies
(Heidelberg, Germany).
Mice
Mice were maintained and sacrificed in accordance with the
European Communities Council Directive of 24th Nov. 1996 and
were approved by the local governmental administration for
animal health (Permit number: 54.2531.31-28/08, government of
the administrative region of Mittelfranken; Genehmigungen zur
Haltung genetisch vera¨nderter Tiere, permit number 820-
8791.2.41, government of the administrative region of Unter-
franken). All efforts were made to minimize suffering. Wild type
(WT) C57BL/6 mice at embryonic (E16 and E18) and adult ages
(P150) were used. We have generated mice deficient for EFhd2 on
a C57Bl/6 background using stem cells from the trans-NIH
Knock-Out Mouse Project (KOMP, https://www.komp.org/)
from Velocigen Regeneron Pharmaceuticals, and described
elsewhere [14].
Immunohistochemistry and b-Galactosidase staining
For immunohistochemistry, brains from adult mice (P150) were
removed, fixed in 4% para-formaldehyed (PFA) in phosphate-
buffered saline (PBS) and embedded in paraffine. Tissue sections
(8 mm) were deparaffinized and antigen was retrieved [15]. Briefly,
sections were heated for 30 min in a Benchmark-Stainer (Roche)
in 10 mM Tris, 1 mM EDTA, 0.05% Tween 20 at 95uC. Sections
were then blocked in 1% bovine serum albumin (BSA) in PBS and
incubated with undiluted hybridoma supernatant containing
EFhd2 mouse antibody (mAb) [16] and anti-mouse Fcc specific
antibody coupled to horseradish peroxidase (HRP, Jackson). To
visualize b-Galactosidase activity, brains were fixed in 0.2%
Glutaraldehyde, 2 mM MgCl2, 5 mM EDTA in PBS for 1 h at
room temperature (RT), washed twice for 30 min in 2 mM
MgCl2, 5 mM EDTA in PBS, and incubated in staining solution
(2 mM X-Gal, 5 mM potassium hexacyanido ferrate (II), 5 mM
potassium hexacyanido ferrate (III), 2 mM MgCl2, 5 mM EDTA
in PBS) for 2 h at 37uC. Brains were washed 3 times for 5 min in
PBS, fixed over-night (ON) in 4% PFA, and washed 3 times for
15 min in PBS. Then, the brains were incubated for 1 h each in
50%/70%/80% ethanol, and analyzed as whole mount or
embedded in 4% agarose and coronally sectioned (100 mm) using
a vibratome (Leica RM2055). Sections were examined with an
inverted microscope (Zeiss Apotome 2) using Zeiss Axiovision 4.8
software (Carl Zeiss).
Primary Cortical Neurons
Cortices from mouse embryos at E16 were dissected, chopped
into 200–500 mm pieces and further mechanically dissociated with
siliconated glass pipettes. Neurons were seeded at a density of
16105 cells/cm2 and cultured in Neurobasal culture media
(Invitrogen) supplemented with L-Glutamine, 2% B27 and
Penicillin-Streptomycin in 5% CO2, 95% humidity at 37uC.
Neurons were transfected with constructs encoding dTomato and
EFhd2Myc [3] using Lipofectamine 2000 (Invitrogen) following
the manufacturer’s instructions. For immunostainings, neurons
were fixed in 4% PFA. Non-specific binding sites were blocked
with immunofluorescence buffer (IFB; PBS supplemented with
0.1% Triton x-100 and 5% normal donkey serum) for 1 h at RT.
Neurons were stained ON with anti-EFhd2 mAb (1:200). Synapses
were labelled with goat anti-synapsin 1a/b antibody (1:1000;
Santa Cruz), rabbit and goat anti-PSD95 (postsynaptic density
protein 95) antibodies (1:200 each; Abcam), rabbit anti-VAMP2
(vesicle-associated membrane protein 2; 1:2000; Synapse Systems).
Neurites were stained with goat anti-tau (microtubule-associated
protein tau; 1:250; Santa Cruz) and rabbit anti-MAP2 (microtu-
bule-associated protein 2; 1:200; Abcam). Next, the samples were
rinsed several times with PBS supplemented with 0.1% Triton x-
100, and incubated with suitable fluorescently labelled secondary
antibodies (Invitrogen) diluted in IFB. After mounting, cells were
either analyzed by confocal microscopy (Zeiss LSM780, digital
resolution 102461024) or with a Zeiss Apotome 2 microscope.
The co-localization of EFhd2 with Tau and MAP2 was assessed
using ImageJ and Volocity (Perkin-Elmer) as previously described
in detail [17,18] and is expressed as Pearson’s co-localization co-
efficient. Co-localization analysis of EFhd2/synapsin and EFhd2/
PSD95 was performed with deconvoluted images derived from an
Olympus Deltavision microscope (606; NA 1.42), using the
JACOP plugin in ImageJ (sbweb.nih.gov/ij/), which provides the
Pearson’s co-localization co-efficient.
Synaptosome preparation by centrifugation
Synaptosomes were prepared as previously published [18,19].
Briefly, forebrains from three to four adult mice were dissected out
and kept in a cold glass-Teflon homogenizer together with 30 ml
of pre-chilled 4 mM Hepes-NaOH; pH 7.3 supplemented with
0.32 M sucrose. Tissue homogenization was performed by 10 up-
down strokes at 900 rpm and the tissue homogenate was
centrifuged at 8006g for 10 min at 4uC. The resulting supernatant
(S1) was centrifuged at 10,0006g for 15 min at 4uC, resuspended
and centrifuged again for 20 min 1000006g to obtain pellet 2 (P2)
representing the crude synaptosome fraction (STS), and superna-
tant (S2). Synaptosomes were broken by osmotic shock, and the
synaptosomal plasmatic membranes (P3; PM) separated by
centrifugation at 25,0006g for 20 min at 4uC. The resulting
supernatant (S3) was further centrifugated at 30,0006gON at 4uC
in order to separate the cytosolic fraction (S4; Cyt) and the
synaptic vesicles fraction (P4; SV). Synaptosomal fractions were
further analyzed by western blot.
Life cell imaging of hippocampal neurons
Hippocampal neuronal cultures were prepared from one to
three days old EFhd2+/+ and EFhd22/2 mice [14]. Newborn mice
were killed by decapitation. Hippocampi were removed from the
brain and transferred into ice-cold Hank’s salt solution, and the
dentate gyrus was removed. After digestion with trypsin (5 mg/
ml), cells were triturated mechanically and plated in MEM
medium, supplemented with 10% fetal calf serum and 2% B27
Supplement (all Invitrogen). Neurons were transfected with
synaptophysin-EGFP under control of a synapsin promoter on
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day 3 in vitro (DIV) with a modified calcium phosphate method as
described [20,21]. Experiments were performed on day DIV 23.
Imaging was performed as described previously (Welzel et al.,
2009; Welzel et al., 2011). Experiments were conducted at room
temperature on a Nikon TI-Eclipse inverted microscope equipped
with a 606,1.2 NA water immersion objective and Perfect Focus
System. Fluorescent dyes were excited by a Nikon Intensilight C-
HGFI through an excitation filter centered at 482 nm using a
dichroic longpass mirror (cut-off wavelength 500 nm). The
emitted light passed an emission band-pass filter ranging from
500–550 nm (Semrock, Rochester) and was projected onto a
cooled EM-CCD camera (iXon DU-885, Andor). Cover slips were
placed into a perfusion chamber (volume= 500 ml) containing
extracellular medium containing (in mM): 144 NaCl, 2.5 KCl, 2.5
CaCl2, 2.5 MgCl2, 10 Glucose, 10 Hepes, pH 7.5. Synaptic
boutons were stimulated by electric field stimulation (platinum
electrodes, 10 mm spacing, 1 ms pulses of 50 mA and alternating
polarity); 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX,
Tocris Bioscience) and 50 mM D-amino-5-phosphonovaleric acid
(D,L-AP5, Tocris Bioscience) were added to prevent recurrent
activity. Images were recorded with 200 ms exposure time at 1 Hz
frame rate. In all experiments resulting image stacks were
converted into ICS file format. Kymographs were generated
using the dropdown menu ‘‘kymograph’’ in MetaMorph 7.5.1.
(MolecularDevices). Only straight axonal segments were selected
for analysis to avoid velocity artifacts originating from factors such
as strong axon covings. Kymographs were analyzed using the
Hough transform as described previously (Welzel et al., 2011).
Protein purification
GST fusion proteins encoded in pGEX2T (GE healthcare) were
induced and purified as described previously [2,16] and dialyzed
into appropriate buffers. A truncated form comprising 560 amino
acids from the N-terminus and containing the motor domain, neck
and part of the stalk of human neuron-specific kinesin-1
(KIF5A560) was expressed in E.coli as fusion protein with a C-
terminal chitin-binding intein tag and purified by binding to chitin
beads followed by removal of the intein-tag by 50 mM DTT-
induced specific self-cleavage [22]. Kinesin was concentrated using
Amicon ultra filter units (Merk Millipore) and stored in motility
buffer (50 mM imidazole, 0.5 mM MgCl2, 0.5 mM EGTA,
0.5 mM DTT, pH 6.8) supplemented with 150 mM NaCl and 1
M glycerol at 280uC. Tubulin was purified from porcine brain
homogenates by two cycles of temperature-dependent disassembly
at 0uC and reassembly at 37uC. Co-purified MAPs were removed
by phosphocellulose ion exchange chromatography [23]. Stabi-
lized MTs were formed by taxol-promoted self-assembly at 37uC
from 2 mg/ml pure tubulin in the MT assembly buffer (20 mM
PIPES, 80 mM NaCl, 1 mM EGTA, 0.5 mM MgCl2, pH 6.8)
supplemented with 0.2 mM GTP and 20 mM taxol. MTs were
usually prepared at the day of usage at least 30 min prior to an
experiment. The purity of kinesin was 75–80%, the purities of
GST, GST-EFhd2 and tubulin were all 95–98% as determined by
SDS-PAGE.
In vitro gliding assay
Gliding assays were performed as described previously [24,25]
MTs were assembled and stabilized as described above. All gliding
assays were performed with pure KIF5A560 in motility buffer
(26.5 mM Imidazol, 9.4 mM PIPES, 0.735 mM EGTA,
0.265 mM DTT, 137.6 mM NaCl, 1.5 mM MgCl2, 0.5 mM
ATP, and 0.004 mM GTP) supplemented with 20 mM taxol. The
gliding assay mixture containing KIF5A560 (0.4 mg/ml), stabilized
MTs (40 mg/ml), and GST or GST-EFhd2 at indicated concen-
trations was incubated 5 min at room temperature prior
transferring it onto casein-coated glass slides. The sample was
covered by a cover slip. MT gliding was visualized by video-
enhanced differential interference contrast microscopy; gliding
velocities were calculated from at least 10 MTs in each sample
using the Argus-20 software (Hamamatsu Photonics). 100%
correspond to the gliding velocity of 1.3 um/sec. All analyses
were performed using a Zeiss Axiophot microscope (Carl Zeiss)
equipped with a Plan-Neofluor 636/1.25 oil immersion objective
(Carl Zeiss), a Chalnicon video camera type C2400-0.1, and the
image processing system Argus-20 (both Hamamatsu Photonics),
which enables background subtraction, and electronic contrast
enhancement. Microtubule movement was documented on a
digital hard-disk recorder (JVC SR-DVM70EU, JVC).
Western blotting
Brains were extracted in cold homogenization buffer (50 mM
Tris, pH 8.0; 2 mM EDTA, 140 mM NaCl) supplemented with
1 mM dithiothreitol (DTT) as well as protease and phosphatase
inhibitors. After homogenization, samples were centrifuged first at
8006g for 10 min. Supernatants (S1) were incubated with 1% of
Triton x-100 for 30 min on ice and centrifuged at 11,0006g for
10 min at 4uC. Neurons were directly lysed in homogenization
buffer containing 1% Triton X-100. 5 to 40 mg of total protein
were loaded were separated by SDS-PAGE and blotted onto
nitrocellulose membranes. Primary antibodies were incubated ON
at 4uC in Tris-buffered saline and 0.1% Tween20 (TBST)
supplemented with 3% BSA (mouse anti-SNAP-25 (clone SMI-
81; 1:1000; Synaptic Systems), mouse anti-synaptophysin (clone
p38; 1:1000; Sigma-Aldrich); mouse anti-b3-tubulin (TUJ 1:2000;
Covance); goat anti EFhd2 (1:500; Everest Biotech), rabbit anti
EFhd2 ([26], 1 mg/ml); goat anti Tau (1:500; Santa Cruz) were
employed to determinate synaptosomal sub-fractions. After several
washes with TBST, blots were incubated with corresponding
secondary antibodies conjugated to horseradish peroxidase and
developed by chemical luminescence techniques.
Statistical Analysis
Data are expressed as mean 6 standard error of the mean
(SEM). Statistical analysis was done with the Student’s t-test for
unpaired variables (two-tailed) when data passed the Kolmogorov-
Smirnov Test (with Dallal-Wilkinson-Lilliefor P value) or other-
wise, as indicated in the figure legends or the main text. Statistics
were calculated using GraphPad Prism software. P-values#0.05
were considered significant (*). ** and ***: p,0.001 and 0.0002,
respectively.
Results
EFhd2 is expressed in the murine cortex and
hippocampus
To determine the expression of EFhd2 in the adult brain we
utilized an EFhd22/2 knockout/lacZ knock-in mouse strain
generated in our laboratory [14]. In heterozygous animals
(EFhd2+/2), one efhd2 allele is replaced by a lacZ reporter gene
(Fig. 1A). The lacZ reporter gene downstream of the efhd2
promoter, resulting in b-galactosidase expression, indicates efhd2
mRNA expression, which we have shown to be strong compared
to other tissues [3]. Hence, EFhd22/+ and EFhd22/2 mice
express b-galactosidase in the adult brain, while protein levels of
EFhd2 are reduced correspondingly (Fig. 1B). Whole mount
staining revealed strong b-galactosidase activity in the forebrain
(Fig. 1C). To determine efhd2 expression in more detail, we
sectioned whole mount stained adult mouse brains coronally
Function of EFhd2 in Neurons
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Figure 1. EFhd2 expression in adult mouse brain determined by lacZ reporter gene expression. (A) Replacement of the murine efhd2
locus by a lacZ reporter gene cassette. E1-4: Exons. Black: coding regions in exons. (B) Lysates of brains of wild-type (+/+), heterozygous (+/2) or
EFhd2-deficient mice (2/2) were subjected to western blot analysis with antibodies indicated on the right. (C) Whole mount lacZ reporter gene
staining of brains of adult mice. (D) Coronal sections of anterior and posterior parts of whole mount stained brains from adult EFhd2+/+, EFhd2+/2
andEFhd22/2 mice.
doi:10.1371/journal.pone.0103976.g001
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(Fig. 1D). Prominent dose-dependent b-galactosidase activity indic-
ative of efhd2 promoter activity was detected in the deeper layers of
the cortex (IV, V, and VI), as well as the dentate gyrus, the CA1 and
CA2 areas of the hippocampus. b-galactosidase activity was also
observed in the thalamus and the olfactory bulb (Fig. 1D).
EFhd2 protein is expressed in embryonic brain tissue and
primary cortical neurons
Next, we showed the presence of the EFhd2 protein in the
cortex, hippocampus, and thalamus of wild-type mouse embryos
(E18) and adult tissue (P150) by western blot analysis (Fig. 2A).
Importantly, we noted that EFhd2 was expressed in all forebrain
areas at embryonic and adult stages (Fig. 2A), the latter of which
confirmed previous findings [4], but embryonic expression has not
been revealed before. As a control, we included non-neuronal
tissue (spleen) of EFhd2+/+, 2/+ and 2/2 mice, confirming the
predominant expression of EFhd2 protein in the adult brain
compared to other organs [3]. Next, we examined the expression
of EFhd2 in cortical neurons, where we observed a moderate up-
regulation of EFhd2 between DIV1 and DIV13 (compare EFhd2
expression relative to Actin), concomitant with steady up-
regulation of tau and the pre-synaptic marker synapsin (Fig. 2B).
Hence, EFhd2 is expressed in embryonic and adult brain as well as
in primary cortical neurons. The EFhd2 protein was up-regulated
roughly two-fold during neuronal maturation in vitro and in
parallel with tau. In complete accordance, EFhd2 protein was
increased roughly two-fold in adult versus embryonic brain tissue.
Immunohistochemistry confirmed the expression of EFhd2 in
the pyramidal layers (layers III–V) and the multiform layer (layer
VI) of the cortex (Fig. 3A). Conversely, EFhd2 was never detected
in the molecular layer (layer I), the external granular layer (layer
II) and the white matter (Fig. 3A). The EFhd2 signal was also
specific in the granular and pyramidal cell laminas of the
hippocampus (Fig. 3B). EFhd2 was associated with cell bodies
but apparently not nuclear. A dot-like neuropil staining (see
arrowheads in Fig. 3B) of EFhd2 was observed in the hippocam-
pus of EFhd2+/+ mice but not of EFhd22/2 mice using anti-
EFhd2 mAb A4.18.18 [16]. Similar results were obtained with the
anti-EFhd2 mAb A4.15.18 [16] (data not shown). An isotype
matched control antibody (IgG1k) did not reveal a specific
staining. The intercellular, dot-like expression of EFhd2 indicated
a staining of neurites or synapses, and we next tested these
possibilities in cultures of primary neurons.
EFhd2 is expressed in neurites marked by tau and MAP2
in murine cortical neurons and is found in proximity to
pre- and post-synaptic markers
We therefore analyzed localization of EFhd2 in primary cortical
neurons by confocal microscopy. The anti-EFhd2 mAb specifically
stained the somatodendritic region and neurites in a punctuate
fashion (Fig. 4A). This staining resembled the EFhd2 staining
pattern observed in situ (Fig. 3B). To determine whether EFhd2 is
associated with axons, which was anticipated due to the previously
published interaction with tau [4], or with dendrites, we
performed co-staining of EFhd2 with tau and MAP2 [27]
(Fig. 4B). This experiment revealed a distinct staining of MAP2
in neurites and the somatodendritic cytoplasm. There were also
neurites that were only positive for tau (see arrows in Fig. 4B), as
the establishment of neuronal polarity, i.e. axon-dendrite specifi-
cation, has taken place under the culture conditions we applied
[27,28]. Interestingly, EFhd2 revealed a clear co-localization with
MAP2 when compared to the isotype control (Fig. 4B). However,
EFhd2 was also present in neurites marked with tau. Quantifica-
tion of the fluorescence signals showed that EFhd2 was associated
with neurites marked by tau to about 30%, but mostly with
neurites marked by MAP2, to about 50% (Fig. 4B; summary in
Fig. 4D). The staining results obtained with the anti-EFhd2 mAb
(dominant staining of MAP2 marked neurites) were confirmed by
Myc-staining in neurons transfected with a Myc-tagged EFhd2
protein [3] (Fig. 4C). We selectively chose neurons that moder-
ately over-expressed EFhd2Myc. In summary, EFhd2 is not only
associated with tau marked neurites, as might have been inferred
from the interaction with mutant tau [4], but also with neurites
marked by MAP2 as well as the cytoplasm of primary neurons. To
further elaborate this result, we investigated whether EFhd2 might
be associated with the pre- and postsynaptic markers synapsin 1 a/
b and PSD95 by deconvolution microscopy. Indeed, there was a
partial co-localization of EFhd2 with the pre-synaptic marker
synapsin 1a/b [29] (Fig. 5A). Quantification revealed that the
fluorescence signals of EFhd2 and synapsin 1a/b overlapped with
a Pearson’s co-localization coefficient of 0.49. Vice versa, the
fluorescence signals of synapsin 1a/b overlapped with EFhd2
signals with a Pearson’s co-localization coefficient of 0.55 (Fig. 5).
In addition, EFhd2 was found in close association with PSD-95
(Fig. 5B), confirming its dendritic localization, but did not directly
co-localize (Pearson’s co-localization coefficients EFhd2/PSD-95:
0.31, PSD-95/EFhd2: 0.14). Hence, using two different marker
systems (MAP2/Tau and Synapsin1/PSD95) we reveal that
EFhd2 is localized in neurites. The punctuate staining pattern
along neurites, and the staining pattern in situ (Fig. 3B) suggested
that EFhd2 colocalizes with transport vesicles; or with synaptic
structures; or both. Hence, EFhd2 could be associated with
transport vesicles delivering synaptic proteins but also be a
synaptic protein. These possibilities are not mutually exclusive.
EFhd2 is associated with the cytosolic and plasma
membrane fractions of biochemically isolated
synaptosomes
To test the possibility that EFhd2 is associated with synapses, we
analyzed synaptosomes prepared by differential centrifugation
[18,19] from brains of adult EFhd2+/+ and EFhd22/2 mice. First,
we assessed to which extent EFhd2 could associate with this
biochemically isolated brain fraction. To this end we analyzed the
amount of EFhd2 protein present in the pelleted fraction (P2 –
STS [synaptosomes]) that was further used to obtain the different
synaptosome fractions and the fraction S2 (not used for further
analysis). Whereas the cytosolic protein b3-tubulin was only to
26% in the P2 fraction, the synaptic marker synaptophysin was
present much more, and EFhd2 was present to 37%, indicating
that a substantial part of EFhd2 can associate with biochemically
prepared synaptosomes (Fig. 6A). Next, we assessed where in
synaptosomes EFhd2 was located. Therefore, the fraction P2
synaptosomes were separated into cytosolic (Cyt), synaptic vesicle
(SV) and plasma membrane (PM) fractions. Using protein markers
for specific fractions, namely b3-tubulin - cytosolic fraction,
synaptophysin - synaptic vesicle fraction and SNAP25 - plasma
membrane [29], we revealed that EFhd2 is present mostly in the
cytosolic and synaptic plasma membrane compartments. The
abundance of the synaptic proteins synaptophysin and SNAP25
was unchanged between EFhd22/2 mice and controls (Fig. 6B).
Taken together, these data revealed that a fraction of EFhd2 is
localized in biochemically isolated synapses [19]. We did not control
these fractions by electron microscopy as in the original publication.
Importantly, however, synapsin, s a synaptic marker, is also found in
these preparations [19] and we found that EFhd2 co-localizes with
synapsin (Fig. 4A) in matured primary neuronal cultures [27]. Thus,
our imaging and our biochemical approach support the notion that
Function of EFhd2 in Neurons
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EFhd2 associates with vesicular structures that might be part of - or
be delivered to - synapses. Ultrastructural analyses in vitro and in
situ will be necessary to address the question of specific synaptic
abundance or accumulation of EFhd2 in the future.
EFhd2 does not impact endocytosis and exocytosis
To test the possibility that lack of the low affinity Ca2+ binding
protein EFhd2 [2] alters synaptic functions, we transfected
primary neurons of EFhd2+/+ and EFhd22/2 mice with
Figure 2. EFhd2 protein expression in embryonic and adult brain regions as well as in cortical neurons. (A) Embryonic (E18) and adult
brains (P150) of wildtype mice were dissected into indicated regions. These regions as well as spleens from adult EFhd22/2, 2/+ and +/+ mice were
lysed and lysates were subjected to 10% SDS-PAGE, followed by western blotting with polyclonal antibodies indicated on the right. Molecular mass
standards are indicated on the left (kDa). Optical densities of EFhd2 bands were normalized to actin bands. Representative of three experiments. (B)
Cultures of E16 cortical neurons were cultured for the indicated days in vitro (DIV) and lysed. Each time point is represented by two lanes showing
two independent cultures. Lysates were subjected to 10% SDS-PAGE, followed by western blotting with antibodies indicated on the right. Molecular
mass standards are indicated on the left (kDa). Optical densities of synapsin1a/b, tau and EFhd2 bands were normalized to actin (n = 8 from 4
experiments; one representative experiment is shown). Data are represented as mean 2/+ SEM.
doi:10.1371/journal.pone.0103976.g002
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Figure 3. Specific detection of EFhd2 protein in murine brain sections. Brains of EFhd2+/+ and EFhd22/2 mice were fixed, sectioned
(horizontal) and stained with anti EFhd2 monoclonal antibody A4.18.18 in the cortex (A) or hippocampus (B), or in the hippocampus with an isotype
matched control antibody (IgG1k, C). Antibodies were detected by secondary anti mouse antibody coupled to horseradish peroxidase and
diaminobenzidine staining. Nuclei were counterstained with Alcian Blue. The pyramidal layers (layers III–V) and the multiform layer (layer VI) of the
cortex, the molecular layer (I), the external granular layer (II) and the white matter are indicated. Representative of at least 10 mice of each genotype.
Similar results were obtained with 2 additional different anti EFhd2 mAb (E7.20.23; A4.15.48) [16].
doi:10.1371/journal.pone.0103976.g003
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synapto-phluorin [30] and monitored synaptic exo- and endocy-
tosis following an electrical stimulus with 200 pulses at 10 Hz
(Fig. 6C). This experiment demonstrated that neither the amount
of exocytosed synaptic vesicles (DF/F0,t+/+=11.0865.25%, DF/
F0,t2/2=11.2063.48%; two-sample t-test: p=0.73) nor the
endocytosis and related kinetics (t+/+=27.1764.56 seconds, t2/
2=28.0162.45 seconds; two-sample t-test: p=0.87) were affected
by the presence of EFhd2.
Figure 4. Co-localization of EFhd2 with neurites marked by tau and MAP2 in murine cortical neurons. (A) Murine cortical neurons (DIV7)
were stained with the primary antibodies anti EFhd2 or an isotype matched control antibody (IgG1k) and analyzed by confocal microcsopy. (B)
Murine cortical neurons were stained with the primary antibodies anti EFhd2, tau and MAP2. Single images were taken by confocal microscopy and
merged (right panel). (C) Murine cortical neurons were double-transfected with constructs encoding dTomato (red) and Myc-tagged EFhd2
(EFhd2Myc; green) and images were taken with an Apoptome. (D) Quantification of the sub-neuronal distribution of EFhd2; data are represented as
mean 6 SEM (*** P,0.001; two-tailed student’s t-test).
doi:10.1371/journal.pone.0103976.g004
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EFhd2 slows down axonal transport and inhibits kinesin
activity in vitro
Nevertheless, the distribution of EFhd2 along axons and
dendrites in a punctuate fashion (Figs. 4 and 5), and its presence
in biochemically isolated synaptosomes without functional effect
on synaptic exocytosis or endocytosis (Fig. 6), raised the possibility
that EFhd2 may be involved in axonal transport. Therefore, we
measured synaptic transport by expressing a synaptophysin-GFP
fusion protein, coupled to an automated image acquisition and
analysis device [21], in primary hippocampal neurons of EFhd2+/+
and EFhd22/2 mice. Interestingly, net axonal transport and
percentages of moving particles were significantly increased in the
absence of EFhd2, whereas the pausing time was not affected
(Fig. 7A, B). Thus, lack of EFhd2 increased the speed of axonal
transport.
We next asked, whether EFhd2 decreased axonal transport by
inhibition of the plus end microtubule motor protein kinesin [11].
Figure 5. Co-localization of EFhd2 with Synapsin and PSD95 revealed deconvolution microscopy. (A and B) DIV11 and DIV13 cortical
neurons were fixed and stained with anti EFhd2 mAb (green), anti-synapsin 1a/b (red) (A) and rabbit anti-PSD95 (red) (B) antibodies. Mounted cells
were analyzed by deconvolution microscopy. Selected areas (insets) were enhanced and visualized in xy and yz dimensions. Images represent 0.2 mm
slices of from a deconvolved image stack. Scale bars represent 5 mm (1 mm in the insets).
doi:10.1371/journal.pone.0103976.g005
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We quantified kinesin activity in a microtubule-gliding assay
[24,31]. In this cell free in vitro assay system, purified neuron
specific kinesin (KIF5A) was coated on a glass surface, overlaid
with polymerized MTs and movement of MTs was analyzed by
microscopy [31]. Interestingly, the recombinant GST-EFhd2
fusion protein [2], but not GST alone, inhibited KIF5A mediated
Figure 6. Synaptic localization of EFhd2 is not required for synapse function in primary hippocampal neurons. (A) Crude
synaptosomes were purified from pooled brains and centrifuged. Equal amounts of the supernatant (S2) and the crude synaptosome fraction (STS;
P2) were subjected to 10% SDS-PAGE, followed by Western Blotting, Ponceau S staining of the membrane and incubation with antibodies as
indicated on the right. The relative distribution of a cytosolic protein (b3-tubulin), a synaptic marker (synaptophysin) and EFhd2 in synaptosomes was
calculated by OD measurement. (B) Equal amounts of protein were obtained from each of the separated synaptosomal (S) fractions (Cyt: cytosolic
fraction, PM: plasma membrane, SV: synaptic vesicles) and subjected to 10% SDS-PAGE, followed by western blotting with antibodies indicated on
the right. b3-tubulin is a marker protein for the cytosolic fraction (Cyt), synaptophysin is a marker protein for synaptic vesicle (SV) fractions and
SNAP25 is a marker for plasma membrane (PM) and synaptic vesicle fractions. Molecular mass standards are indicated on the left (kDa).
Representative of two independent experiments performed with each three EFhd2+/+ and three EFhd22/2mice. (C) Normalized fluorescence intensity
profiles of synapto-phluorin transfected primary neurons of EFhd2+/+ and EFhd22/2 mice. Neurons were stimulated with 200 pulses at 10 Hz. Insets
show exemplary fluorescence images. Error bars indicate SD. Scale bar, 10 mm. n= 6 transfections.
doi:10.1371/journal.pone.0103976.g006
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MT gliding in a dose-dependent manner (Fig. 7C). These data
indicated that kinesin mediated transport was modulated in the
presence of EFhd2. We therefore measured the ATPase activity of
KIF5A in the absence or presence of recombinant GST-EFhd2.
We did not observe a significant inhibition of kinesin mediated
ATPase activity by GST-EFhd2 (data not shown). Thus, EFhd2
slowed kinesin mediated MT gliding, which might be a
consequence of reduced kinesin-MT interaction.
Discussion
Strong EFhd2 expression in the brain was detected in the grey
matter, including the cortex and hippocampus. Thus, the lacZ
expression pattern in EFhd2-gene targeted mice and anti-EFhd2
immunohistochemistry outlined a specific EFhd2 expression in the
pyramidal layers of the cortex, in the dentate gyrus, and in the
CA1-CA2 regions of the hippocampus. These findings are in line
with the in situ hybridizations described in the Allen brain atlas
Figure 7. Inhibitory effects of EFhd2 on microtubule motor mediated transport in cellular and cell-free systems. (A) Primary
hippocampal neurons of EFhd2+/+ and EFhd22/2 mice were transfected to express synaptophysin-EGFP. The velocity of vesicles marked with
synaptophysin-EGFP was determined and is plotted both against the relative frequency and as normalized velocity (EFhd2+/+= 1; mean 2/+ SEM).
The average velocities are 59.982/+16.76 nm/s (EFhd22/2; 25 kymographs) vs. 47.062/+12.73 nm/s (EFhd2+/+; 10 kymographs) (mean2/+ SD;
p = 0.0063, two tailed t-test). Results represent 4 experiments. (B) Primary hippocampal neurons of EFhd2+/+ and EFhd22/2 mice were transfected to
express synaptophysin-EGFP. The number and pausing times of moving vesicles marked with synaptophysin-EGFP were quantified and data of 4
experiments was represented as mean6 SEM (*** P,0.001; two tailed student’s t-test). (C) Purified KIF5A560 was coated to glass slides and incubated
with polymerized MTs in the absence or presence of GST or increasing amounts GST-EFhd2. The gliding velocity was determined and is shown as %
of the buffer control that was set as 100% (corresponding to a gliding velocity of 1.3 um/sec). Data are represented as mean 6 SD of five
independent experiments. In every experiment, gliding velocities of 10–15 microtubules were measured for each experimental condition. *** P,
0.001; one way ANOVA followed by a Dunett’s multiple comparisons test.
doi:10.1371/journal.pone.0103976.g007
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where areas with a high density of neurons also intensively stain for
efhd2, whereas regions with fewer neurons also show less efhd2
expression. Brain regions that mostly consist of white matter (e.g.
the corpus callosum) do not show efhd2 expression (see Allan
Brain Atlas, Experiment 69671911). Interestingly, these findings
were also confirmed in microarrays from human brain (Allan
Brain Atlas, EFhd2 human microarrays).
In the developing embryo, we show for the first time that the
EFhd2 protein is expressed in the cortex, hippocampus, and
thalamus of E18 brain, indicative of expression of EFhd2 during
brain development. EFhd2 was also expressed in primary cortical
neurons and became up-regulated during neuronal differentiation
in a biphasic manner. This might be an indication that EFhd2 is
involved in specific neuronal differentiation processes. Along this
line, tau also plays an important physiological role during axon
branching and in synaptic plasticity and EFhd2 has been shown to
interact with a mutant form of tau [4]. Increased levels of EFhd2
correlated with the presence of an additional band of tau. Thus, a
possible interplay between tau and EFhd2 may functionally affect
certain specific aspects of neuronal development [12].
To unravel potential functions of EFhd2 in the central nervous
system, we studied the intracellular localization of EFhd2. We
found EFhd2 expressed in fine granular structures in the neuropil
throughout the CNS with prominent expression in regions that
contain dense neuronal populations in rodents and human brain
(e.g. in the hippocampus), while EFhd2 expression was absent in
EFhd22/2 mice. We also found co-labelling of EFhd2 with axonal
and dendritic markers in cortical neurons. A co-localization of
roughly 40% was observed for EFhd2 with pre-synaptic markers.
Co-staining of EFhd2 with synaptic markers was indicative of a
potential role in synaptic transmission. This finding led us to
investigate EFhd2 expression in synaptosomes. We detected
EFhd2 in biochemically isolated synaptosomes, with the highest
abundance in the cytosolic fraction. Other proteins that are
predominantly found in the cytosolic fraction, for example
amphiphysin, function in synaptic vesicle endocytosis [32].
Analysis of the Drosophila homolog of EFhd2 (DSwip) also
revealed a potential role in cell-cell communication: DSwip
accumulates transiently in foci at the contact sites of fusing
myoblasts and either directly or indirectly regulates calcium-
dependent exocytosis of the electron-dense vesicles of the pre-
fusion complex in myoblasts [33]. Taking these data into
consideration, we next analyzed synaptic exocytosis and endocy-
tosis in EFhd22/2 mice, but did not find any significant difference
compared to the control group. This finding might be explained
by redundancy of other proteins involved in vesicle exocytosis in
the nervous system. For example, even depletion of synaptophysin,
a major synaptic vesicle protein involved in endocytosis of synaptic
vesicles, does not result in major differences in phenotype or
neurotransmitter release [34–36]. In line with the proposed
function of DSwip, however, the yet to be molecularly defined
association of EFhd2 with vesicular structures might be compatible
with a function in establishing and breaking down contact between
pre- and post-synaptic membrane structures [11,12], that is,
synaptic plasticity.
The distribution of EFhd2 in neurites marked both with tau and
MAP2 suggested a universal role in neurites. To our surprise we
found an increase in transport velocity and an increase in the
number of moving particles in EFhd22/2 mice. The idea of
EFhd2 as a regulator of axonal transport is fully compatible with a
possible function of EFhd2 in establishing and breaking down
contacts between pre- and post-synaptic membrane structures
[11]. In addition, the strongest expression of EFhd2 was found in
the cytosolic fraction of our biochemically isolated synaptosome
preparation. In this fraction, also cytoskeleton markers like b3-
tubulin are highly abundant. These data are compatible with
EFhd2 being part of a conserved regulatory cytoskeletal network
[10,37].
To address this possibility further, we aimed to identify in a cell
free system the proteins that functionally interact with EFhd2.
KIF5A-induced MT gliding was decelerated by addition of a
GST-EFhd2 fusion protein to this system, indicating a dose-
dependent functional interaction between EFhd2 and KIF5A. A
potential mechanism of the interference with kinesin activity
towards MTs could be inhibition of MT binding to kinesin by
EFhd2.
EFhd2 might also exert effects on dynein (MT minus end
motor), specifically since differential regulation of dynein and
kinesin motor proteins by locally altered concentrations of tau
have been described earlier [38]. On the other hand, neither tau-
deficient nor tau-overexpressing mice do show alterations of
axonal transport in vivo [39]. Thus, alternatively and not mutually
exclusive, EFhd2 might in neurons also interact with components
of the actin cytoskeleton [8,10,40], like gelsolin does, which
inhibits axonal transport in a Ca2+ dependent manner [41].
In our hands, EFhd22/2 mice did not develop any obvious
neuronal phenotype. How can this be reconciled with a proposed
role for EFhd2 in tauopathies [4,9], such as Alzheimer’s disease
[42]? Normal mice do not develop neurodegenerative diseases
such as Alzheimer’s disease and thus, transgenic mouse models are
being used to mimick certain aspects of human neurodegenera-
tion. Hence, it is not surprising that EFhd22/2 mice do not
develop an obvious phenotype in that respect. However, the
phenotype of induced neurodegeneration, or other neurologic
diseases (for review see [7]), upon genetic or environmental
challenge, might be modulated in one or the other direction in the
absence of EFhd2. For instance, reduction of endogenous tau
protein ameliorates onset of disease in an amyloid-beta transgenic
mouse model [43]. Alterations in both anterograde as well as
retrograde transport are sufficient to induce neurodegeneration
[44]. Thus it is tempting to speculate that EFhd2 might be
involved in transport of cargo relevant for neurodegenerative
diseases, in combination with or without tau. Hence our data will
in the future contribute to more specifically testing the hypotheses
that EFhd2 is involved 1) in tauopathies [4,9] with regard to
intracellular transport, and 2) in establishment of synaptic
plasticity.
Taken together, we reveal here for the first time the wide spread
neuronal expression of EFhd2 and propose that EFhd2 is a
neuronal protein controlling basal neuronal functions exerted
through kinesin.
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